Search for: [Abstract = "n IIP \(p=0.27\)as well as GCS dose \(p=0.16 and p=0.16\), symptom duration \(p=0.95 and p=0.2\), DLco %. \(p=0.86 for EBV and p=0.78 for WZhet\), the BAL profile \(p=0.19, p=0.29, p=0.59 for EBV and p=0.25, p=0.32, and p=0.53 for WZhet\), the type of immunological response. The presence of EBV and WZhet in IPF was significantly more frequent compared to other ILD of known etiology \(p<0.001 for EBV and p=0.017 for WZhet\). Conclusions\: The Epstein\-Barr virus in the brush biopsy material from patients with IPF is significantly more frequent compared to other IIP, as well as presence of the mutated form WZhet, which was not detected in the control group. There was no association between presence of EBV and WZhet and the duration and advancement of IPF, the duration of GCS therapy and its dose, the cellular profile in BAL and the type of immunological response against EBV. EBV as well as WZhet were significantly more common among IPF patients in comparison with other ILD of known origin."]

Number of results: 1